Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Global Blood Therapeutics, Inc.
About GBT
Global Blood Therapeutics, Inc. is a biopharmaceutical company that discovers, develops and delivers treatments. The Company is focused on Oxbryta (voxelotor), which is the Food and Drug Administration (FDA) approved medicine that inhibits sickle hemoglobin (HbS) polymerization, the root cause of red blood cell sickling in sickle cell disease (SCD). It is also advancing its pipeline program in SCD with inclacumab, a P-selectin inhibitor in Phase III development to address pain crises associated with the disease, and GBT021601 (GBT601), the Company’s next-generation HbS polymerization inhibitor. The Company is focused on areas of the United States, Europe, the Gulf Cooperation Council (GCC), region of the Middle East, and Latin America.
Find out what a historical investment in Global Blood Therapeutics, Inc. would be worth today using our GBT stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy GBT shares in Australia?
Buying GBT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Global Blood Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in GBT
What is the ticker symbol of Global Blood Therapeutics, Inc.?
The ticker symbol for Global Blood Therapeutics, Inc. is GBT.
How much is one share of GBT?
One share of GBT is valued at $68.48 as of 05 June 2026.
What is the market capitalisation of Global Blood Therapeutics, Inc. GBT?
As of 05 June 2026 Global Blood Therapeutics, Inc. has a market cap of -.
What is the 52-week high for Global Blood Therapeutics, Inc. stock?
The Global Blood Therapeutics, Inc. 52-week high stock price is $NaN.
What is the 52-week low for Global Blood Therapeutics, Inc. stock?
The Global Blood Therapeutics, Inc. 52-week low stock price is $NaN.
Can I buy GBT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy GBT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GBT on Stake
- Buy GBT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of GBT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
GBT related stocks